- ORCID iD
- 0000-0002-7029-6201
Show
Sort by
-
- Journal Article
- A1
- open access
Dual-ligand PROTACS mediate superior target protein degradation in vitro and therapeutic efficacy in vivo
-
- Journal Article
- A1
- open access
Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in quadrivalent influenza vaccine vaccinated mice
-
- Journal Article
- A1
- open access
Combinatorial screening of biscarbamate ionizable lipids identifies a low reactogenicity lipid for lipid nanoparticle mRNA delivery
-
- Journal Article
- A1
- open access
Lipid nanoparticle encapsulation empowers poly(I:C) to activate cytoplasmic RLRs and thereby increases its adjuvanticity
-
- Journal Article
- A1
- open access
Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia
-
- Journal Article
- A1
- open access
Successful batch and continuous lyophilization of mRNA LNP formulations depend on cryoprotectants and ionizable lipids
-
- Journal Article
- A1
- open access
Lipid nanoparticle delivery alters the adjuvanticity of the TLR9 agonist CpG by innate immune activation in lymphoid tissue
-
Smart hydrogels delivered by high pressure aerosolization can prevent peritoneal adhesions
-
- Journal Article
- A1
- open access
RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine
-
Lipid-polyglutamate nanoparticle vaccine platform